Castle Biosciences (CSTL) Q2 2024 Earnings

2MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.01
-0.7
-0.4
-0.09

Details

Expected EPS
-0.332046
Actual EPS
-0.09
Surprise EPS
0.24
Surprise Percent
+72.9%

Description

Castle Biosciences (CSTL) has reported earnings of -0.09 per share for Q2 2024.

0 Comments

Share your thoughts